SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-058823
Filing Date
2021-11-15
Accepted
2021-11-12 18:01:04
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0921_180lifesciences.htm   iXBRL 10-Q 1112271
2 CERTIFICATION f10q0921ex31-1_180lifesci.htm EX-31.1 9890
3 CERTIFICATION f10q0921ex31-2_180lifesci.htm EX-31.2 10116
4 CERTIFICATION f10q0921ex32-1_180lifesci.htm EX-32.1 3562
5 CERTIFICATION f10q0921ex32-2_180lifesci.htm EX-32.2 3887
6 GRAPHIC image_001.jpg GRAPHIC 2410
  Complete submission text file 0001213900-21-058823.txt   6492289

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20210930.xsd EX-101.SCH 92214
8 XBRL CALCULATION FILE atnf-20210930_cal.xml EX-101.CAL 33926
9 XBRL DEFINITION FILE atnf-20210930_def.xml EX-101.DEF 325292
10 XBRL LABEL FILE atnf-20210930_lab.xml EX-101.LAB 684917
11 XBRL PRESENTATION FILE atnf-20210930_pre.xml EX-101.PRE 344273
12 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921_180lifesciences_htm.xml XML 812686
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 211405305
SIC: 2834 Pharmaceutical Preparations